Its downstream signaling pathway may be attenuated in obesity by chronic exposure to TNF-α through NF-κB-mediated upregulation of IKKε and TBK1, which inhibit cAMP signaling via phosphodiesterase 3B [239]. The gene discussed is NFKB1; the disease is obesity disorder.